Skip to main content
Netherlands News in English

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Image
The first three vaccines against Covid-19 approved for use in Europe were made by Pfizer, AstraZeneca and Moderna. February 2021
The first three vaccines against Covid-19 approved for use in Europe were made by Pfizer, AstraZeneca and Moderna. February 2021 - Credit: cristianstorto / DepositPhotos
Health
Coronavirus
Covid-19
coronavirus vaccine
vaccine
coronavirus vaccination
Tuesday, 9 March 2021 - 18:27

Share this article:

Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window

8.4% of Netherlands adults now partially vaccinated against Covid-19

Dutch healthcare workers have administered at least one dose of a Covid-19 vaccine to 1,207,904 adults in the Netherlands. That equates to 8.4 percent of nearly 14.4 million people aged 18 and older in the country, according to data from public health agency RIVM through March 7.

That includes 19,259 people between the ages of 75 and 79 living in their own homes. Invitations to people in that group were first sent out last week, the RIVM said, and about three percent of Netherlands residents in that group have been inoculated.

Some 411,935 adults have been given their second dose of one of the three vaccines used in Europe, just shy of 2.9 percent of adults. The Netherlands ranks in the bottom third of EU nations for the portion of the population fully vaccinated against Covid-19, but tied for eighth with Slovenia for partially vaccinated adults.

Though the Pfizer vaccine is approved for use in Europe with people as young as 16, it is not yet used by 16- and 17-year-olds in the Netherlands. Vaccines from Moderna and AstraZeneca were only approved for adults 18 and up.

Roughly 6.9 percent of the entire population, including children, have been at least partially vaccinated.

Provisional data from the RIVM showed that about 36,200 more injections were administered on Monday. That pushed the seven-day average down to 39,513. Though the country received 208 thousand vaccine doses from BioNTech/Pfizer and 216 thousand doses from AstraZeneca last week, it was anticipating a delay of over 210 thousand doses from the latter this month.

The RIVM previously warned that this could lead to a temporary slowdown in the vaccination process.

More like this

Image
New visualisation of the Covid-19 virus
Health minister not upset about rising Covid cases; Holiday parties could cause new wave
Image
Medical Care Minister Bruno Bruins tells the Tweede Kamer he is alright moments after collapsing from exhaustion. 18 March 2020
Dutch parliament to question virologist, fmr. Healthcare Min. today in Covid inquiry
Image
Meningococcal Vaccine Vial
Dutch health council rejects inclusion of meningococcal B vaccine in national programme
Image
Child using a laptop
Kids who failed exams during Covid at-home learning struggling more in higher education
Make NL Times your top Google source

Follow us:

Latest stories

  • Suriname court convicts Dutch driver in passenger bus crash that killed five
  • Netherlands economy will stall without urgent infrastructure investments: Heijmans CEO
  • Mark van Bommel named new head coach of Belgium's national football team
  • Dutch gov't doing enough to protect locals in climate deal with Tata Steel, court rules
  • Europe slaps Google with €890 mil. fine for prioritizing own services in search results

Top stories

  • Thialf ice skating stadium hit by ransomware attack
  • Romanian gang considered Amsterdam sex workers their property; Exploited dozens of women
  • Netherlands to implement points system for unsafe driving
  • New U.S. import tariffs: Netherlands facing 10% along with other EU Member States
  • Walkers set off on last day of Vierdaagse; 42,450 people finished hardest 3rd day

© 2012-2026, NL Times, All rights reserved.

Footer menu

  • Change Privacy Settings
  • Privacy Policy
  • Contact
  • Partner Content